Total Funding
39
66
Total FundingGrant raised
Growth Score
0 pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
104298
Olilux Biosciences provides medical diagnosis services that help in delivering tuberculosis detection alternatives.
- Mireille Kamariza: Co-founder, CEO
- Manu Prakash: Co-Founder, Scientific Advisor
About the Company
Olilux Biosciences provides medical diagnosis services that help in delivering tuberculosis detection alternatives. The company's first product is a novel small molecule called DMN-Tre, developed by Mireille Kamariza (Founder and CEO of OliLux) and Carolyn Bertozzi (Founder and Scientific Advisor) at Stanford University.
Women Founded
